A Repeated Study of KRN23 in Adults With X-Linked Hypophosphatemia

Written by ClinicalTrials.gov

Category: Bone diseases

Published: 15 April 2011

Condition: X-linked Hypophosphatemia
Intervention: Drug: KRN23
Sponsors: Kyowa Hakko Kirin Pharma, Inc.; Kyowa Hakko Kirin Company, Limited
Recruiting - verified August 2011

Details: Last Updated: 15 April 2011

Find, Use, Share, Expand Orthopaedic Information

Improving orthopaedic care, education and research using Internet technologies